Table 1.
Clinical and laboratory characteristics of the psoriatic patients with ALT serum concentration within normal range and with ALT above the limit. Data are shown as median and quartiles (Q1 first quartile; Q3 third quartile). Significant differences between the groups are shown as: *p < 0.05
| Characteristics | Psoriasis normal ALT (n = 73) |
Psoriasis ALT above the limit (n = 12) |
P-value |
|---|---|---|---|
| Age [years] | 54.0 (41.0–59.0) | 47.5 (41.5–50.5) | NS |
| Psoriasis duration [months] | 17.0 (6.0–28.0) | 20.0 (6.5–29.5) | NS |
| PASI | 8.0 (5.0–12.5) | 14.9 (10.6–22.0) | 0.011* |
| BMI | 27.2 (23.9–30.9) | 28.8 (24.5–37.2) | NS |
| CRP [mg/dl] | 2.4 (1.0–4.9) | 6.5 (2.9–10.6) | 0.025* |
| WBC [× 103/ml] | 6.9 (5.8–8.2) | 7.3 (6.4–7.7) | NS |
| Glucose [mg/dl] | 87.0 (77.0–98.0) | 94.0 (84.0–101.0) | NS |
| Vitamin D [ng/ml] | 15.3 (11.6–22.4) | 13.9 (6.7–21.2) | NS |
| Cholesterol [mg/dl] | 175.0 (153.0–199.0) | 185.0 (162.0–194.0) | NS |
| Triglyceride [mg/dl] | 109.0 (79.0–149.0) | 105.0 (77.0–151.0) | NS |
PASI – psoriasis area and severity index, BMI – body mass index, CRP – C-reactive protein, WBC – white blood cells, NS – non significant.